Renalytix plc stock is down -45.56% since 30 days ago. The next earnings date is Mar 28, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 December’s closed higher than November.
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. KidneyIntelX is a diagnostic platform that employs an artificial intelligence algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems.